According to results from a Phase I/IIa trial at The University of Texas
MD Anderson Cancer Center, treatment with cord blood-derived chimeric
antigen receptor (CAR) natural killer (NK)-cell therapy targeting CD19
resulted in clinical responses in a...
Scott MervilleCD19 CAR NK-cell therapy achieves 73% response rate in patients with
#leukemia and lymphoma with no major toxicities. #immunotherapy
Scott MervilleOpinion | These Were the Iowa Caucuses We Always Needed politi.co/395Fki2 via @politico
"Thanks to this monumental whiff, we need never spend a moment’s attention on the Iowa caucuses again."
Despite the back-to-back collapses that defined the endings of the 2018 and 2019 seasons for the Chicago Cubs, everybody is presumably in for another wild ride in 2020. Well, not everybody.
Scott MervilleColumn: Is everyone in for the Chicago Cubs? - Chicago Tribune
“If not for you (WGN), the Cubs would’ve been just another losing franchise without a national following, a Midwest version of the Padres.”
Researchers from The University of Texas MD Anderson Cancer Center have
shown that a decision aid delivered through tobacco quitlines
effectively reaches a screening-eligible population and results in
informed decisions about lung cancer screening.
Scott MervilleLung cancer screening decision aid delivered through tobacco quitlines
improves informed decision-making bit.ly/2GJXJ7Q #LungCancer #endcancer